Health Regulator geared up for smooth transition to licensing of Class A and B Medical Devices Ruchika Sharma15 Sept 2022 5:30 PM ISTNew Delhi: The reconstituted National Medical Device Promotion Council (NMDPC) under the Department of Pharmaceuticals, in its first meeting held at...
Biocon Bribery Case: Delhi HC grants bail to Joint Drug Controller, 2 others Farhat Nasim6 Sept 2022 5:35 PM ISTNew Delhi: In a major relief to Joint Drug Controller of the Central Drugs Standard Control Organisation (CDSCO), Dr S Eswara Reddy, Delhi High Court...
Rs 9 lakh Biocon bribery case: CBI charge sheet against Joint Drug Controller, Biocon Biologics executives Ruchika Sharma27 Aug 2022 2:00 PM ISTIn a coordinated operation, the CBI had arrested all five accused.
Five persons of Karnal private hospital booked for allegedly manhandling drug department team Adity Saha14 Aug 2022 1:45 PM ISTKarnal: In order to inquire about a medical negligence case of transfusing wrong blood into a patient, a joint team of the Food and Drug...
No relief to Medical Device makers: Health Minister declines to relax deadline for registration of medical devices Rahul Verma26 July 2022 5:30 PM ISTMajority of the medical devices in India will come under the licensing regime from October 1 as notified by the central government, with Union Health...
No relief to medical device makers: Health Minister declines to relax last date for registration of medical devices Ruchika Sharma26 July 2022 1:20 PM ISTAs per the rules, unregistered devices will not be deemed authorised and manufacturers may face penal action, an official source said.
Bribery scandal: CBI approaches Delhi HC after special court denies custody of Joint drugs controller, Biocon Biologics official Ruchika Sharma29 Jun 2022 12:12 PM ISTNew Delhi: The CBI approached the Delhi High Court on Tuesday challenging a lower court order denying it the custody of those arrested in the CDSCO...
Boehringer Ingelheim's empagliflozin gets CDSCO nod for heart failure with preserved ejection fraction Medical Dialogues Bureau19 May 2022 4:19 PM ISTNew Delhi: Boehringer Ingelheim, one of the world's leading, research-driven pharmaceutical companies, has received approval from the Central Drugs...
Setback: AstraZeneca proposal to market, manufacture Olaparib rejected by CDSCO panel Dr. Divya Colin23 April 2022 5:03 PM ISTNew Delhi: In a major setback to AstraZeneca, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has...
Sun Pharma gets CDSCO panel okay for phase 3 trial of Pimavanserin Dr. Divya Colin29 Jan 2022 12:51 PM ISTNew Delhi: Pharmaceutical major, Sun Pharma has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Covishield, Covaxin get regular market approval MD Bureau20 Jan 2022 4:39 PM ISTNew Delhi: India's two main vaccines, Bharat Biotech's Covaxin and Serum Institute of India's Covishield, on Wednesday got the nod for regular market...
CDSCO approves extension of Covaxin shelf life up to 12 months Ruchika Sharma21 Dec 2021 1:00 PM ISTCovaxin Open Vial is stable at 2 to 8 degrees Celsius for 28 days and not required to be discarded immediately in a day or at the end of immunisation...
